NO974204D0 - Anvendelse av nitrogenoxyddonorer eller nitrogenoxydinhibitorer for regulering av cervicaldilatering og utvidbarhet - Google Patents

Anvendelse av nitrogenoxyddonorer eller nitrogenoxydinhibitorer for regulering av cervicaldilatering og utvidbarhet

Info

Publication number
NO974204D0
NO974204D0 NO974204A NO974204A NO974204D0 NO 974204 D0 NO974204 D0 NO 974204D0 NO 974204 A NO974204 A NO 974204A NO 974204 A NO974204 A NO 974204A NO 974204 D0 NO974204 D0 NO 974204D0
Authority
NO
Norway
Prior art keywords
nitric oxide
extensibility
inhibitors
cervical dilatation
donors
Prior art date
Application number
NO974204A
Other languages
English (en)
Other versions
NO974204L (no
NO318598B1 (no
Inventor
Kristof Chwalisz
Robert E Garfield
Original Assignee
Schering Ag
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Univ Texas filed Critical Schering Ag
Publication of NO974204D0 publication Critical patent/NO974204D0/no
Publication of NO974204L publication Critical patent/NO974204L/no
Publication of NO318598B1 publication Critical patent/NO318598B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
NO19974204A 1995-03-14 1997-09-12 Anvendelse av nitrogenoksiddonorer eller nitrogenoksidinhibitorer for regulering av cervixdilatasjon og -utvidelsesevne NO318598B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14
PCT/US1996/003540 WO1996028145A1 (en) 1995-03-14 1996-03-14 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility

Publications (3)

Publication Number Publication Date
NO974204D0 true NO974204D0 (no) 1997-09-12
NO974204L NO974204L (no) 1997-11-13
NO318598B1 NO318598B1 (no) 2005-04-18

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974204A NO318598B1 (no) 1995-03-14 1997-09-12 Anvendelse av nitrogenoksiddonorer eller nitrogenoksidinhibitorer for regulering av cervixdilatasjon og -utvidelsesevne

Country Status (26)

Country Link
US (1) US6333350B1 (no)
EP (1) EP0814785B1 (no)
JP (1) JP4579349B2 (no)
KR (2) KR100434239B1 (no)
CN (1) CN1151781C (no)
AT (1) ATE377417T1 (no)
AU (1) AU713172B2 (no)
CA (1) CA2214779A1 (no)
CZ (1) CZ292395B6 (no)
DE (1) DE69637313T2 (no)
ES (1) ES2297838T3 (no)
HU (1) HUP9800826A3 (no)
ID (1) ID20742A (no)
IL (1) IL117496A (no)
IS (1) IS4555A (no)
MX (1) MX9707007A (no)
MY (1) MY116500A (no)
NO (1) NO318598B1 (no)
NZ (1) NZ305169A (no)
PL (1) PL183461B1 (no)
RU (1) RU2199346C2 (no)
SK (1) SK124197A3 (no)
TW (1) TW421594B (no)
UA (1) UA57703C2 (no)
WO (1) WO1996028145A1 (no)
ZA (1) ZA962089B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100434239B1 (ko) 1995-03-14 2004-06-09 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경관 팽창 및 신장 조절을 위한 산화질소 공여체 또는산화질소 억제제의 용도
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
US20050113409A1 (en) * 2003-09-03 2005-05-26 Pharmacia Corporation Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
PL178174B1 (pl) * 1993-11-16 2000-03-31 Garfield Robert E Kompozycje farmaceutyczne do hamowania kurczliwości macicy lub stymulowania kurczliwości macicy
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
KR100434239B1 (ko) 1995-03-14 2004-06-09 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 경관 팽창 및 신장 조절을 위한 산화질소 공여체 또는산화질소 억제제의 용도

Also Published As

Publication number Publication date
UA57703C2 (uk) 2003-07-15
TW421594B (en) 2001-02-11
JP4579349B2 (ja) 2010-11-10
KR19980703060A (ko) 1998-09-05
US6333350B1 (en) 2001-12-25
WO1996028145A1 (en) 1996-09-19
PL322252A1 (en) 1998-01-19
NO974204L (no) 1997-11-13
KR20040004515A (ko) 2004-01-13
RU2199346C2 (ru) 2003-02-27
NZ305169A (en) 1999-10-28
JPH11502200A (ja) 1999-02-23
IL117496A0 (en) 1997-03-18
ZA962089B (en) 1997-08-27
CN1151781C (zh) 2004-06-02
AU5311796A (en) 1996-10-02
CZ292395B6 (cs) 2003-09-17
ES2297838T3 (es) 2008-05-01
PL183461B1 (pl) 2002-06-28
MX9707007A (es) 1998-06-30
KR100434239B1 (ko) 2004-06-09
EP0814785A1 (en) 1998-01-07
CZ285197A3 (cs) 1998-03-18
CN1182366A (zh) 1998-05-20
CA2214779A1 (en) 1996-09-19
NO318598B1 (no) 2005-04-18
IS4555A (is) 1997-09-05
SK124197A3 (en) 1998-06-03
DE69637313T2 (de) 2008-09-04
ATE377417T1 (de) 2007-11-15
EP0814785B1 (en) 2007-11-07
AU713172B2 (en) 1999-11-25
ID20742A (id) 1999-02-25
IL117496A (en) 2002-12-01
DE69637313D1 (de) 2007-12-20
HUP9800826A3 (en) 1998-08-28
MY116500A (en) 2004-02-28
KR100434238B1 (ko) 2004-07-16
HUP9800826A1 (hu) 1998-07-28

Similar Documents

Publication Publication Date Title
DE68921273T2 (de) System zum kontinuierlichen Behandeln von Halbleitersubstraten.
NO952469L (no) Terapautisk kombinasjon som inneholder interferon
WO1992018160A3 (en) Method for inhibiting adhesion of white blood cells to endothelial cells
NO961994D0 (no) Behandling av klimakteriske forstyrrelser med nitrogenoksidsyntasesubstrater og/eller -donorer
TW272940B (en) /
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE69221501T2 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
CA2222303A1 (fr) Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
ZA933023B (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds.
NO932388D0 (no) Fremgangsmaate til fraktur-syrebehandling av undervannsformasjoner
NO974204D0 (no) Anvendelse av nitrogenoxyddonorer eller nitrogenoxydinhibitorer for regulering av cervicaldilatering og utvidbarhet
NO942650D0 (no) Farmasöytisk kombinasjonspreparat
ATE202599T1 (de) Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO983906D0 (no) Anvendelse av karboniske anhydraseinhibitorer for behandling av makulær ödem
ATE212833T1 (de) Verwendung von stickstoffoxid-synthase-substrat und/oder -donor oder stickstoffoxidhemmer zur herstellung von medikamenten zur behandlung von störungen der uterinen kontraktilität
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
DE59611327D1 (de) Verwendung von flupirtin zur prophylaxe und therapie von erkrankungen, die mit einer beeinträchtigung des hämatopoetischen zellsystems einhergehen
AU2968792A (en) Method of preventing reocclusion of arteries
NO20002481L (no) Kombinasjonsterapi for behandling av AIDS
ATE233570T1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
DK0725644T3 (da) Anvendelse af budesonid til fremstilling af et lægemiddel til behandling af tilstande, som beror på en reduceret enterisk v
NO961046D0 (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
NO981020L (no) Transdermalt terapautisk system for silatranforbindelser